About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

LevineConservationModelandColorectalPatients

NCT06499129·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

KTO Karatay University

With

Necmettin Erbakan University

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Between the ages of 18-75
Diagnosed with primary and new colorectal cancer (Stage II and III),
The decision to start the FOLFOX treatment protocol has been taken,
Having a smartphone,
Being literate,
Ability to speak and understand Turkish,
Open to communication and cooperation.

You may not be if

History of neuropathy or diabetes,
History of hypothyroidism, renal failure,
Hearing, speech and vision problems,
Receiving radiotherapy or immunotherapy,
Psychiatric diagnosis or ongoing treatment.

The record

StatusCompleted

PhaseNo phase

Taking part68

StartedJun 2025

UpdatedJan 15, 2026

Conditions

Fatigue Peripheral Neuropathy Anxiety

Where1

Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)

Clareo Health | LevineConservationModelandColorectalPatients